ReviewJournal of clinical medicine2021
Ocular Manifestations of Behçet's Disease: An Update on Diagnostic Challenges and Disease Management.
Review in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 33 citations in OpenAlex.
- Association between choroidal vascularity index and disease activity in Behçet uveitis using BOS24 and FFA scores.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026Article
- Exploring the Involvement ofLife (Basel, Switzerland) · 2026Review
- Management of Severe Behçet's Disease.Current rheumatology reports · 2026Review
- Retinal thickness and microvascular alterations in the diagnosis of behcet's disease: a case-control study.BMC medical imaging · 2026Article
- Determinants of Baseline Ophthalmic Screening and Its Association with Long-Term Treatment Persistence in Patients with Rheumatic Diseases Initiating Hydroxychloroquine: A Nationwide Cohort Study.Patient preference and adherence · 2026Article
- Rare presentation of Behçet's disease in a 22-year-old male with combined retinal artery and vein occlusions.American journal of ophthalmology case reports · 2025Article
- Behçet's Syndrome Overall Damage Index performance and validation in an adult Egyptian cohort.Archives of rheumatology · 2024Article
- TraceEyeDisease: a web-based database for investigating trace elements and their imbalances in eye diseases.BMC research notes · 2024Article
- The Current and Novel Imaging Modalities for Ocular Vasculitis in Behcet's Disease: A Review.Cureus · 2024Review
- Novel genetic variants of HLA gene associated with Thai Behcet's disease (BD) patients using next generation sequencing technology.Scientific reports · 2024Article
- Neuro-Behçet With a Thalamic Lesion: A Case Report.Cureus · 2023Article
- [Noninfectious posterior uveitis : Clinical aspects, diagnostics, management and treatment].Die Ophthalmologie · 2023Article
- Treatment Options in Pediatric Behçet's Disease.Paediatric drugs · 2023Review
- From Retinal Vasculitis to Stroke, from Systemic Findings to Diagnosis, the Necessity of Multidisciplinary Management in Behçet's Disease: A Case Report.Case reports in ophthalmologyArticle
- Fern-Like Pattern on Ultra-Widefield Fluorescein Angiography Across Various Uveitic Conditions.Romanian journal of ophthalmologyObservational
- Behcet's disease in a tertiary eye hospital in Pakistan.Therapeutic advances in rare diseaseArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Behçet's disease is a systemic vasculitis that affects multiple organs. The most common manifestations are oral and genital ulcerations and recurrent uveitis. Uveitis can be an initial symptom in 10-20% of cases and leads to blindness in 16-25% of patients. The management of this disease is evolving due to the clinical phenotypes recently described in the literature and increasing focus on the detection of subclinical inflammation to enable correct therapeutic decisions. The first line treatment is azathioprine, followed by various immunosuppressive and biological agents as alternatives in severe or refractory cases. This review summarizes scientific articles about the etiology of, diagnostic tools for and treatment of the ocular manifestations of Behçet's disease available in the PubMed database from 1 January 2016 to 1 May 2021. A multidisciplinary approach is necessary to effectively prevent permanent damage and thus improve the life quality of the patients. Therefore, it is crucial to raise awareness of the common clusters of symptoms, use of modern imaging methods, such as ocular computed tomography and fluorescein angiography, and novelty treatment algorithms to enable early diagnosis and appropriate management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.